Spoken Alpha
LONA
LeonaBio, Inc.
Overview
LeonaBio develops small-molecule therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis.
LeonaBio, Inc is a Healthcare company operating in Biotechnology with a $46.5M market cap.
Most recent reported earnings: Q3 FY2026 (Nov 4, 2026).
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-10-04.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
- Q3 FY20262026-11-04EPS— vs $-0.62—Rev— vs ——EODHD
- Q2 FY20262026-08-13EPS$-0.80 vs $-1.90+57.9%Rev$0 vs ——EODHD
- Q1 FY20262026-05-06EPS$-1.73 vs $-2.50+30.8%Rev$0 vs ——EODHD
- Q4 FY20252026-03-26EPS$-18.92 vs $-1.27-100.0%Rev$0 vs ——EODHD
- Q3 FY20252025-11-05EPS$-1.68 vs $-1.22-37.7%Rev$0 vs ——EODHD
- Q2 FY20252025-08-06EPS$-0.18 vs $-0.180.0%Rev$0 vs ——EODHD
- Q1 FY20252025-05-08EPS$-2.30 vs $-2.40+4.2%Rev$0 vs ——EODHD
- Q4 FY20242025-02-26EPS$-0.38 vs $-0.380.0%Rev$0 vs ——EODHD
- Q3 FY20242024-11-06EPS$-7.50 vs $-0.71-100.0%Rev$0 vs ——EODHD
- Q2 FY20242024-07-31EPS$-7.00 vs $-7.37+5.0%Rev— vs ——EODHD
- Q1 FY20242024-05-14EPS$-6.90 vs $-7.98+13.5%Rev— vs ——EODHD
- Q4 FY20232024-02-21EPS$-7.10 vs $-9.62+26.2%Rev— vs ——EODHD
- Q3 FY20232023-11-08EPS$-8.70 vs $-8.14-6.9%Rev— vs ——EODHD
- Q2 FY20232023-08-09EPS$-7.80 vs $-8.40+7.1%Rev— vs ——EODHD
- Q1 FY20232023-05-10EPS$-7.30 vs $-5.80-25.9%Rev— vs ——EODHD
- Q4 FY20222023-03-22EPS$-0.79 vs $-0.790.0%Rev— vs ——EODHD
- Q3 FY20222022-11-09EPS$-5.30 vs $-6.53+18.8%Rev— vs ——EODHD
- Q2 FY20222022-08-14EPS$-6.50 vs $-6.500.0%Rev— vs ——EODHD
- Q1 FY20222022-05-11EPS$-5.60 vs $-5.37-4.3%Rev— vs ——EODHD
- Q4 FY20212022-03-23EPS$-0.44 vs $-0.440.0%Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | — | $-0.62 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-13 | $-0.80 | $-1.90 | +57.9% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-06 | $-1.73 | $-2.50 | +30.8% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-03-26 | $-18.92 | $-1.27 | -100.0% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $-1.68 | $-1.22 | -37.7% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-0.18 | $-0.18 | 0.0% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-08 | $-2.30 | $-2.40 | +4.2% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-02-26 | $-0.38 | $-0.38 | 0.0% | $0 | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-7.50 | $-0.71 | -100.0% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-07-31 | $-7.00 | $-7.37 | +5.0% | — | — | — | EODHD |
| Q1 FY2024 | 2024-05-14 | $-6.90 | $-7.98 | +13.5% | — | — | — | EODHD |
| Q4 FY2023 | 2024-02-21 | $-7.10 | $-9.62 | +26.2% | — | — | — | EODHD |
| Q3 FY2023 | 2023-11-08 | $-8.70 | $-8.14 | -6.9% | — | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-7.80 | $-8.40 | +7.1% | — | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-7.30 | $-5.80 | -25.9% | — | — | — | EODHD |
| Q4 FY2022 | 2023-03-22 | $-0.79 | $-0.79 | 0.0% | — | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-5.30 | $-6.53 | +18.8% | — | — | — | EODHD |
| Q2 FY2022 | 2022-08-14 | $-6.50 | $-6.50 | 0.0% | — | — | — | EODHD |
| Q1 FY2022 | 2022-05-11 | $-5.60 | $-5.37 | -4.3% | — | — | — | EODHD |
| Q4 FY2021 | 2022-03-23 | $-0.44 | $-0.44 | 0.0% | — | — | — | EODHD |
Source: EODHD. LONA reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Mark James LittonCEO8 mono recorded callsCurrent
- Robert RenningerCFO8 mono recorded callsCurrent
- Mark WorthingtonGENERAL COUNSEL and CCO8 mono recorded callsCurrent
- Martin Javier SanCHIEF MEDICAL OFFICER2 yr 7 mono recorded callsCurrent
- Kevin ChurchCHIEF SCIENTIFIC OFFICER2 yr 10 mono recorded callsCurrent
- Leen KawasCEO5 mono recorded callsFormer
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LONA.
$ curl https://api.spokenalpha.com/v1/companies/LONAFAQ
Frequently asked about LONA
Where can I find LeonaBio, Inc.'s (LONA) earnings call transcripts?
Spoken Alpha indexes LONA's earnings call transcripts at https://spokenalpha.com/companies/LONA. Each call links to attributed speakers and parsed analyst Q&A. LeonaBio, Inc.'s own investor relations page is at https://leonabio.com/investors/.
When was LeonaBio, Inc.'s most recent earnings call?
LeonaBio, Inc. (LONA) held its most recent earnings call on 2022-03-24, covering fiscal Q4 2021.
What sector is LONA in?
LeonaBio, Inc. (LONA) operates in the Healthcare sector (Biotechnology industry).